Applied Molecular Transport appoints Earl Douglas as general counsel
Applied Molecular Transport, a clinical-stage biopharmaceutical company, announced that it has appointed Earl Douglas (pictured) as General Counsel. In his new role, Earl will assume leadership responsibilities for all legal activities of the Company. He will become a member of the AMT Executive Team, reporting to chief executive officer and co-founder of AMT, Tahir Mahmood, Ph.D.
Mr. Douglas joins with more than 30 years of deep experience, leading and building legal organizations for biotechnology and medical device organizations. He most recently served as general counsel at Kiverdi. He has also served as general counsel and corporate secretary at BioMimetic Therapeutics (acquired by Wright Medical Group), Spinal Dynamics (acquired by Medtronic), and OPX Biotechnologies (acquired by Cargill). He also previously served as Counsel at Wilson Sonsini Goodrich & Rosati, and earlier in his career, practiced as an associate with Weil, Gotshal & Manges.
“I am thrilled to be joining AMT at such an important point in the Company’s growth,” said Earl Douglas, general counsel of AMT. “I look forward to supporting the Company’s future progress with this accomplished team.” “Earl brings extensive legal and strategic advisory experience that will be invaluable as we continue to advance our promising pipeline of novel, oral biologic medicines” stated Tahir Mahmood.